The Aqilion operational team scouts for and evaluates new project ideas and manages the project development process. Our experienced team members have diverse backgrounds and cutting-edge knowledge that enable us to provide the projects with hands-on support. Together with partners, project managers and selected specialists, our team manages and supports projects from idea to exit. The operational team also coordinates the partner network, handles communications and manages Aqilion and the individual projects.

Sarah Fredriksson
Sarah Fredriksson
CEO
Read more
Sarah Fredriksson
Sarah Fredriksson
CEO

PhD and M.Sc. from Lund University. CEO of AQILION AB since 2017. She has many years’ experience from research and development work in the life science sector from both academia and industry. Her background includes experiences as an entrepreneur and from positions as CEO. She founded Genovis AB and during her time as CEO the company was listed on First North, Nasdaq OMX Nordic. Most recently, she was the CEO of Edvince AB. Currently she is the chairman of Genovis AB (publ) and Edvince AB as well as board member of LU Holding, Respiratorius AB (publ), SwedeNanoTech AB and SwedenBIO.

Torgeir Vaage
Torgeir Vaage
CFO
Read more
Torgeir Vaage
Torgeir Vaage
CFO

In current position since May 2020. MSc in Business and Economics from Norwegian School of Economics and PhD in Business Administration from University of California, Berkeley. He has more than 20 years’ combined experience in the life science and financial sectors. Prior to joining Aqilion, he has held CFO and CEO positions in several early stage life science companies in the Nordic life science industry. Before moving into biotech, Torgeir spent six years as senior equity analyst and partner in ABG Sundal Collier; and before that, he was senior equity analyst in Handelsbanken and management consultant at AT Kearney in Oslo.

Susanna Dahlgren
Susanna Dahlgren
Senior Project Leader
Read more
Susanna Dahlgren
Susanna Dahlgren
Senior Project Leader

In current position since 2018. PhD in clinical immunology from Karolinska Institutet and B.Sc. in microbiology from Stockholm University. She has robust experience from academic research and pharmaceutical development, and is specialized in project management, medical affairs and scientific communications. Most recently she held the Global Market Intelligence Manager position at Polypeptide Group and previously international senior positions with ALK in Denmark and AstraZeneca in Sweden. She is the project manager for a number of Aqilion’s development projects.

Carina Eldh
Carina Eldh
Chief Controlling Officer
Read more
Carina Eldh
Carina Eldh
Chief Controlling Officer

In the current position since 2019, employed since 2011. In her role at Aqilion, she is responsible for the company’s and portfolio company’s daily financial and administrative tasks. She has 20 years’ experience in accounting, auditing and taxation matters and has previous held positions at KPMG and other accounting firms, the Swedish Tax Agency and Öresundskraft.

Fredrik Lindgren
Fredrik Lindgren
Vice President, Chief Business Officer
Read more
Fredrik Lindgren
Fredrik Lindgren
Vice President, Chief Business Officer

In current position since 2018. PhD, M.Sc. in chemistry from Umeå University. He has a background in the pharmaceutical industry with key positions in the area of business development processes at AstraZeneca and Umetrics AB among others. Most recently, he held the position of Senior Director, Head of Global Business Development at LEO Pharma.

Jeanette Folking
Jeanette Folking
Vice President, Chief Development Officer
Read more
Jeanette Folking
Jeanette Folking
Vice President, Chief Development Officer

In current position since 2018, employed since 2007. PhD, M.Sc. in Pharm., followed by post-doc studies in the US. She has gained broad experience from key international positions as medical director, project manager for drug development and head of clinical trials in the pharma industry at Novartis, Perstorp Pharma, Searle Scandinavia, Tigran Technologies and the CDC. Currently she is a project manager at Laccure AB.

Martin Johansson
Martin Johansson
Senior Director Medicinal Chemistry
Read more
Martin Johansson
Martin Johansson
Senior Director Medicinal Chemistry

In current position since 2019. PhD., Associate Professor in organic chemistry and M.Sc. chemical engineering at Lund University. Almost 20 years’ experience in medicinal chemistry and preclinical research and development. Former Chief Scientific Officer at Respiratorius AB and Senior Research Scientist at AstraZeneca, Discovery R&D.

Jan Törnell
Jan Törnell
Chief Medical Scientist
Read more
Jan Törnell
Jan Törnell
Chief Medical Scientist

In current position since 2018. MD, PhD. Jan Törnell has been engaged in Aqilion/PULS since 2012 through board assignments in portfolio companies, project manager/CEO and as innovator. He is the former global Vice President Strategy, AstraZeneca Oncology & Infection. Professor, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg. Chairman of Glactone Pharma AB, LIDDS AB (publ) and Innoext AB as well as board member of Diaprost AB and NeuroVive Pharmaceuticals AB (publ).